Allianz
TECH icon

Allianz’s Bio-Techne TECH Stock Holding History

Allianz’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$176K Buy
+2,435
New +$175K ﹤0.01% 394

Other funds holding TECH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Allianz's TECH Position: Q3 2026 in Review

Allianz opened a new position in Bio-Techne (TECH) in Q3 2026: 2,435 shares worth $176K. The stake represents ﹤0.01% of the portfolio and ranks #394 among its holdings.

451 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Allianz held 2,435 shares of Bio-Techne worth $176K as of Q3 2026.
  • Bio-Techne was a new Allianz position in Q3 2026.
  • Bio-Techne made up ﹤0.01% of Allianz's portfolio in Q3 2026, its #394 holding.
  • 451 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Allianz's 13F filing for Q3 2026, filed 12 Nov 2026.